Jade Biosciences, Inc.
JBIO
$12.00
$0.383.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | 21.66% | 15.81% | |||
| Total Depreciation and Amortization | 500.00% | -137.50% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -59.58% | -43.03% | |||
| Change in Net Operating Assets | -158.36% | 15.43% | |||
| Cash from Operations | -9.75% | -7.47% | |||
| Capital Expenditure | 58.09% | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -109,244.12% | -- | |||
| Total Debt Issued | -107.10% | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 206.25% | -1,856.00% | |||
| Cash from Financing | -100.00% | 27,429.71% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -199.90% | 978.93% | |||